Leadership is shifting from time management to energy management. Learn how reducing friction, protecting focus and ...

A new statewide program the city of Durango is pursuing could make residential recycling fees a thing of the past. Durango ...

Wednesday is Earth Day, and WKBN sat down with the director of the Ohio Environmental Protection Agency to learn more about ...

On a weeklong immersion in Mexico City, Master’s in Global Business and Society student Ioanna Rellou ’26 studied ethical leadership styles and envisioned the kind of leader she wants to become.

LOS ANGELES (AP) — A judge has allowed Lil Nas X to enter a mental health diversion program intended to lead to the dismissal of charges of attacking Los Angeles police officers. Feuding couples, ...

LOS ANGELES (AP) — A judge has allowed Lil Nas X to enter a mental health diversion program intended to lead to the dismissal of charges of attacking Los Angeles police officers. Judge Alan Schneider ...

The performance-based lead generation company provides agents with exclusive, high-intent buyer and seller leads in their county. No upfront fees and no advertising risk. Local Real Estate Leads, a ...

The program, which recently received a grant from the Governor's office, aims to redirect people with substance abuse issues away from the criminal justice system and toward rehabilitation and ...

In the corporate world, an executive suite dominated by women is a rarity. Even more unusual is a company where the majority of shares are held by women. Now, one Canadian firm has both. Sail Outdoors ...

White House responds to Spain closing airspace to US military Arnold Schwarzenegger’s 28-year-old son wins first bodybuilding competition Barbie's dream fest? More like a nightmare warehouse, event ...

Allogene Therapeutics, Inc. (NASDAQ:ALLO) is one of the penny stocks with potential to rise 1000 percent. Allogene Therapeutics said on March 12, 2026, that its lead program, cemacabtagene ...

Shares of Dianthus Therapeutics (DNTH) spiked on Thursday after the company announced that the FDA agreed with several proposed changes related to clinical development of its lead candidate, ...